Company Location Amount Technology Focus (Date)
(C$, M)*
Bioniche Inc. London, Ontario 2.4 Therapeutics for bladder cancer
(ME, TSE:BNC) and interstitial cystitis (8/98)
CliniChem Development Inc. Montreal 150 Antiviral and anticancer
(ME, TSE:BCC.A; NASDAQ:CCHE) therapeutics and vaccines (6/98)
Haemacure Corp. Montreal 6.8 Bioadhesives (8/98)
(ME, TSE:HAE)
Hemosol Inc. Toronto 7.3 Blood substitutes (7/98)
(TSE:HML)
Inflazyme Pharmaceuticals Ltd. Vancouver, 6 Therapeutics that act by regulating gene
(VSE:IZP; OTC Bulletin Board:IZYPF) British Columbia expression; inflammatory diseases (6/98)
Nymox Corp. Montreal 4.1 Alzheimer's disease diagnostics
(ME:NMX; NASDAQ:NYMXF) (4/98)
QLT PhotoTherapeutics Inc. Vancouver, 23 Photodynamic therapy (7/98)
(TSE:QLT; NASDAQ:QLTIF) British Columbia
StressGen Biotechnologies Corp. Victoria, 23.2 Immunotherapy products to treat cancer
(TSE:SSB) British Columbia and prevent infectious diseases (6/98)
Theratechnologies Inc. (ME:TH) Montreal 11.25 Therapeutics for AIDS, cardiovascular
disease, prostate cancer; photodynamic
treatment of bone marrow cancers (5/98)
Tm Bioscience Corp. (VSE:TMC) Toronto 14.8 Genomics; DNA products (6/98)
TOTAL: C$248.85M
NOTES:
* Amounts are quoted in Canadian dollars. The exchange rate on 9/10/98 was C$1.52/US$1.
ME = Montreal Exchange; TSE = Toronto Stock Exchange; VSE = Vancouver Stock Exchange

No Comments